Clinical Scorecard: Evaluating the Effectiveness of the Vesical Imaging-Reporting and Data System (VI-RADS): A Comprehensive Multi-Institutional Systematic Review and Meta-Analysis for Future Clinical Guidelines

At a Glance

Key Highlights

• VI-RADS provides a standardized mpMRI-based 5-point scale to predict muscle invasiveness in bladder cancer preoperatively.
• Meta-analyses demonstrate excellent diagnostic accuracy of VI-RADS in discriminating NMIBC from MIBC.
• Current challenges include optimizing diagnostic settings, reproducibility across MRI scanners and readers, and defining optimal VI-RADS cut-off thresholds (≥3 vs ≥4) for MIBC.

Guideline-Based Recommendations

Diagnosis

• Use VI-RADS scoring on mpMRI prior to TURBT to assess muscle invasiveness in bladder cancer patients.
• Apply standardized MRI acquisition protocols consistent with original VI-RADS guidelines (including 1.5 or 3 Tesla magnets, T2WI, DWI, and DCE sequences).
• Ensure interpretation by GU radiologists with at least 5 years of experience to improve diagnostic accuracy.

Management

• Incorporate VI-RADS score into therapeutic decision-making algorithms for bladder cancer, including selection for secondary resection or neoadjuvant therapy.
• Consider VI-RADS in evaluating radiographic response in MIBC undergoing neoadjuvant regimens.
• Use VI-RADS to potentially avoid extended trans-detrusor resections by guiding biopsy sampling.

Monitoring & Follow-up

• Monitor reproducibility and inter-reader agreement across different MRI scanners and radiologists with varying experience.
• Evaluate ongoing clinical trials and prospective data to refine VI-RADS thresholds and predictive value.

Risks

• Potential variability in diagnostic accuracy due to differences in MRI equipment and reader expertise.
• Uncertainty remains regarding optimal VI-RADS cut-off thresholds for defining muscle invasiveness, which may impact clinical decisions.

Patient & Prescribing Data

Patients with bladder cancer undergoing preoperative staging before TURBT or cystectomy.

VI-RADS scoring aids in stratifying patients by muscle invasion risk, guiding surgical and neoadjuvant treatment planning.

Clinical Best Practices

• Adopt VI-RADS mpMRI protocols standardized to original criteria for consistent imaging quality.
• Engage experienced GU radiologists in image acquisition and interpretation to enhance diagnostic reliability.
• Use VI-RADS scores in conjunction with histopathological confirmation to guide clinical management.
• Support multi-institutional collaboration and data sharing to improve evidence base and refine VI-RADS application.

References

• Original VI-RADS criteria publication
• PRISMA guidelines for systematic reviews